Form D Explorer
EIKONOKLASTES THERAPEUTICS, INC. · CIK 1805698

Report a data issueCitable research briefCompare issuerPrivate research collection

EIKONOKLASTES THERAPEUTICS, INC.

CIK 1805698 · Corporation · Inc. DELAWARE · CINCINNATI, Ohio · Pharmaceuticals

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
1
Amendments
1
Activity
Jul 29, 2025
through Oct 6, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldJul 29, 2025 · DOct 6, 2026 · D/ALater minus earlier
Reported offering amount$15,764,780$18,638,880$2,874,100
Reported amount sold$13,555,109$16,055,106$2,499,997
Reported investor count—15—
Reported minimum investment$0$0$0

Earlier SEC source: 0001805698-25-000002 · Later SEC source: 0001805698-26-000001

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D/A · Oct 6, 2026

Reported offering amount
$18,638,880
Reported exemptions
Rule 506(b)
Reported amount sold
$16,055,106

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Form D filings (2)